Parenteral Delivery of Peptides and Proteins - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 605

[283] Shidhaye SS, Vaidya R, Sutar S, Patwardhan A, Kadam VJ. Solid lipid nanoparticles
and nanostructured lipid carriers—innovative generations of solid lipid carriers. Curr
Drug Delivery 2008;5:324-31.
[284] Muller RH, Olbrich C. Lipid matrix-drug conjugates particle for controlled release of
active ingredient. United States Patent 6770299, 2004.
[285] Souto EB, Doktorovová S. Chapter 6: solid lipid nanoparticle formulations pharmacoki-
netic and biopharmaceutical aspects in drug delivery. Methods Enzymol 2009;464:105-29.
[286] Yuan H, Jiang SP, Du YZ, Miao J, Zhang XG, Hu FQ. Strategic approaches for improv-
ing entrapment of hydrophilic peptide drugs by lipid nanoparticles. Colloids Surf B
Biointerfaces 2009;70:248-53.
[287] García-Fuentes M, Torres D, Alonso MJ. New surface-modified lipid nanoparticles as
delivery vehicles for salmon calcitonin. Int J Pharm 2005;296:122-32.
[288] García-Fuentes M, Torres D, Alonso MJ. Design of lipid nanoparticles for the oral deliv-
ery of hydrophilic macromolecules. Colloids Surf B Biointerfaces 2002;27:159-68.
[289] Morel S, Ugazio E, Cavalli R, Gasco MR. Thymopentin in solid lipid nanoparticles. Int
J Pharm 1996;132:259-61.
[290] Trotta M, Cavalli R, Carlotti ME, Battaglia L, Debernardi F. Solid lipid micro-particles
carrying insulin formed by solvent-in-water emulsion-diffusion technique. Int J Pharm
2005;288:281-8.
[291] Almeida AJ, Souto E. Solid lipid nanoparticles as a drug delivery system for peptides
and proteins. Adv Drug Deliv Rev 2007;59:478-90.
[292] Caliceti P, Brossa A, Salmaso S, Bersani S, Elvassore N, Bertucco A. Preparation of
protein loaded solid lipid nano-particles by compressed fluid process. Proc Intern Symp
Control Release Bioactive Materials 2006;33:383.
[293] Gualbert J, Shahgaldian P, Coleman AW. Interactions of amphiphilic calix (4) arene-
based solid lipid nanoparticles with bovine serum albumin. Int J Pharm 2003;257:
69-73.
[294] Ugazio E, Cavalli R, Gasco MR. Incorporation of cyclosporin A in solid lipid nanopar-
ticles (SLN). Int J Pharm 2002;241:341-4.
[295] Hu FQ, Hong Y, Yuan H. Preparation and characterization of solid lipid nanoparticles
containing peptide. Int J Pharm 2004;273:29-35.
[296] Pedersen N, Hansen S, Heydenreich AV, Kristensen HG, Poulsen HS. Solid lipid
nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands. Eur J
Pharm Biopharm 2006;62:155-62.
[297] Almeida AJ, Runge S, Müller RH. Peptide-loaded solid lipid nanoparticles (SLN):
influence of production parameters. Int J Pharm 1997;149:255-65.
[298] Rudolph C, Schillinger U, Ortiz A, Tabatt K, Plank C, Müller RH, et al. Application of
novel solid lipid nanoparticle (SLN)-gene vector formulations based on a dimeric HIV-
1 TAT-peptide in vitro and in vivo . Pharm Res 2004;21:1662-9.
[299] Martins S, Sarmento B, Ferreira DC, Souto EB. Lipid-based colloidal carriers for
peptide and protein delivery-liposomes versus lipid nanoparticles. Int J Nanomed
2007;2:595-607.
[300] Mehnert W, Mäder K. Solid lipid nanoparticles—production, characterization and appli-
cations. Adv Drug Deliv Rev 2001;47:165-96.
[301] Kamath KR, Park K. Biodegradable hydrogels in drug delivery. Adv Drug Del Rev
1993;11:59-84.
[302] Ito T, Fraserb IP, Yeoa Y, Highleya CB, Bellasa E, Kohane DS. Anti-inflammatory func-
tion of an in situ crosslinkable conjugates hydrogel of hyaluronic acid and dexametha-
sone. Biomaterials 2007;28:1778-86.